An Efficient Method for the Expression and Purification of Aβ(M1-42)

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Advances in amyloid research are contingent upon enhanced access to beta-amyloid peptide (Aβ).
• The N-terminal methionine-extended Aβ, Aβ(M1-42), is a widely utilized form of Aβ with properties similar to natural Aβ(1-42).
• Current methods for Aβ(1-42) isolation involve costly and complex enzymatic cleavage steps.

Purpose of the Study:

• To report an efficient and cost-effective method for the expression and purification of Aβ(M1-42).
• To develop a method for producing ¹⁵N-labeled Aβ(M1-42).
• To establish a simple approach for expressing and purifying Aβ(M1-42) variants with familial mutations.

Main Methods:

• Development of a straightforward bacterial expression system for Aβ(M1-42) and its labeled variants.
• Optimization of purification protocols to yield high-purity peptide.
• Construction of recombinant plasmids for expressing familial mutation-containing Aβ(M1-42) peptides.

Main Results:

• An efficient method yielding approximately 19 mg/L of pure Aβ(M1-42) from bacterial culture.
• The entire process is completed in 3 days using simple and inexpensive steps.
• Successful expression and purification of Aβ(M1-42) peptides with familial mutations.

Conclusions:

• The developed methods provide significantly improved access to Aβ(M1-42) and its variants.
• These techniques simplify peptide production, reducing costs and complexity.
• The improved availability of Aβ is expected to facilitate further research in amyloid-related diseases.